Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pignone M"" wg kryterium: Autor


Tytuł :
More Evidence to Help Guide Decision Making About Aspirin for Primary Prevention.
Autorzy :
Pignone M; Dell Medical School, University of Texas, Austin, Texas (M.P.).
DeWalt DA; University of North Carolina School of Medicine, Chapel Hill, North Carolina (D.A.D.).
Pokaż więcej
Źródło :
Annals of internal medicine [Ann Intern Med] 2019 Jul 16; Vol. 171 (2), pp. 149.
Typ publikacji :
Letter; Comment
MeSH Terms :
Aspirin*
Primary Prevention*
Decision Making ; Platelet Aggregation Inhibitors
Opinia redakcyjna
Tytuł :
What Is So Hard About Aspirin for Primary Prevention?
Autorzy :
Pignone M; Department of Internal Medicine, Dell Medical School, University of Texas-Austin, Austin, Texas. Electronic address: pignone@austin.utexas.edu.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Jun 18; Vol. 73 (23), pp. 2930-2931.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Aspirin*
Cardiovascular Diseases*
Humans ; Platelet Aggregation Inhibitors ; Primary Prevention
Opinia redakcyjna
Tytuł :
More Evidence to Help Guide Decision Making About Aspirin for Primary Prevention.
Autorzy :
Pignone M; Dell Medical School, University of Texas, Austin, Texas (M.P.).
DeWalt DA; University of North Carolina School of Medicine, Chapel Hill, North Carolina (D.A.D.).
Pokaż więcej
Źródło :
Annals of internal medicine [Ann Intern Med] 2018 Dec 04; Vol. 169 (11), pp. 804-805. Date of Electronic Publication: 2018 Nov 27.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Decision-Making*
Primary Prevention*
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Aspirin/*therapeutic use
Cardiovascular Diseases/*prevention & control
Age Factors ; Aged ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Aspirin/adverse effects ; Humans ; Middle Aged ; Risk Assessment
Czasopismo naukowe
Tytuł :
Aspirin for primary prevention: a challenging decision.
Autorzy :
Pignone M; Department of Medicine, University of North Carolina - Chapel Hill, Chapel Hill, NC (M.P.).
Pokaż więcej
Źródło :
Journal of the American Heart Association [J Am Heart Assoc] 2014 Aug 21; Vol. 3 (4). Date of Electronic Publication: 2014 Aug 21.
Typ publikacji :
Editorial
MeSH Terms :
Aspirin/*therapeutic use
Cardiovascular Diseases/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Primary Prevention/*methods
Decision Making ; Humans ; Patient Participation ; Risk Assessment
Opinia redakcyjna
Tytuł :
Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men.
Autorzy :
Pignone M; Cecil Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA, pignone@med.unc.edu.
Earnshaw S
McDade C
Pletcher MJ
Pokaż więcej
Źródło :
Journal of general internal medicine [J Gen Intern Med] 2013 Nov; Vol. 28 (11), pp. 1483-91. Date of Electronic Publication: 2013 May 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Markov Chains*
Aspirin/*economics
Neoplasms/*economics
Neoplasms/*mortality
Primary Prevention/*economics
Aspirin/administration & dosage ; Cost-Benefit Analysis/economics ; Cost-Benefit Analysis/methods ; Humans ; Male ; Middle Aged ; Primary Prevention/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.
Autorzy :
Pignone M; Department of Medicine, University of North Carolina, 5039 Old Clinic Building, CB7110, Chapel Hill, NC 27599-7110, USA. />Williams CD
Pokaż więcej
Źródło :
Nature reviews. Endocrinology [Nat Rev Endocrinol] 2010 Nov; Vol. 6 (11), pp. 619-28. Date of Electronic Publication: 2010 Sep 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Aspirin/*therapeutic use
Cardiovascular Diseases/*prevention & control
Diabetes Complications/*prevention & control
Aged ; Aspirin/adverse effects ; Aspirin/pharmacology ; Drug Resistance ; Female ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Myocardial Infarction/prevention & control ; Practice Guidelines as Topic ; Primary Prevention ; Randomized Controlled Trials as Topic ; Risk Factors ; Stroke/epidemiology ; Stroke/prevention & control
Czasopismo naukowe
Tytuł :
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
Autorzy :
Pignone M; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Alberts MJ
Colwell JA
Cushman M
Inzucchi SE
Mukherjee D
Rosenson RS
Williams CD
Wilson PW
Kirkman MS
Pokaż więcej
Źródło :
Circulation [Circulation] 2010 Jun 22; Vol. 121 (24), pp. 2694-701. Date of Electronic Publication: 2010 May 27.
Typ publikacji :
Congress
MeSH Terms :
Aspirin/*therapeutic use
Cardiovascular Diseases/*prevention & control
Diabetes Complications/*complications
Platelet Aggregation Inhibitors/*therapeutic use
American Heart Association ; Aspirin/adverse effects ; Dose-Response Relationship, Drug ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Risk Factors ; Societies, Medical ; United States
Tytuł :
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
Autorzy :
Pignone M; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Alberts MJ
Colwell JA
Cushman M
Inzucchi SE
Mukherjee D
Rosenson RS
Williams CD
Wilson PW
Kirkman MS
Pokaż więcej
Corporate Authors :
American Diabetes Association
American Heart Association
American College of Cardiology Foundation
Źródło :
Diabetes care [Diabetes Care] 2010 Jun; Vol. 33 (6), pp. 1395-402.
Typ publikacji :
Journal Article
MeSH Terms :
Aspirin/*therapeutic use
Cardiovascular Diseases/*prevention & control
Diabetes Complications/*prevention & control
Diabetes Mellitus/*drug therapy
Platelet Aggregation Inhibitors/*therapeutic use
American Heart Association ; Diabetes Mellitus/physiopathology ; Humans ; Societies, Medical ; United States
Czasopismo naukowe
Tytuł :
Aspirin use among adults aged 40 and older in the United States: results of a national survey.
Autorzy :
Pignone M; General Internal Medicine Division, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Anderson GK
Binns K
Tilson HH
Weisman SM
Pokaż więcej
Źródło :
American journal of preventive medicine [Am J Prev Med] 2007 May; Vol. 32 (5), pp. 403-407.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aspirin/*therapeutic use
Cardiovascular Diseases/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Aging ; Female ; Health Surveys ; Humans ; Male ; Middle Aged ; National Health Programs ; Odds Ratio ; Physician-Patient Relations ; Risk Assessment ; United States
Czasopismo naukowe
Tytuł :
Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis.
Autorzy :
Pignone M; Department of Medicine, Division of General Medicine, University of North Carolina, 5039 Old Clinic Building, Chapel Hill, NC 27599, USA. pignone@med.unc.edu
Earnshaw S
Pletcher MJ
Tice JA
Pokaż więcej
Źródło :
Archives of internal medicine [Arch Intern Med] 2007 Feb 12; Vol. 167 (3), pp. 290-5.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Aspirin/*economics
Aspirin/*therapeutic use
Cardiovascular Diseases/*economics
Cardiovascular Diseases/*prevention & control
Fibrinolytic Agents/*economics
Fibrinolytic Agents/*therapeutic use
Aged ; Cardiovascular Diseases/etiology ; Cost-Benefit Analysis ; Drug Costs ; Female ; Humans ; Markov Chains ; Middle Aged ; Quality-Adjusted Life Years ; Risk Assessment
Czasopismo naukowe
Tytuł :
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.
Autorzy :
Pignone M; University of North Carolina Division of General Internal Medicine, and RTI-University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina 27599-7110, USA. pignone@med.unc.edu
Earnshaw S
Tice JA
Pletcher MJ
Pokaż więcej
Źródło :
Annals of internal medicine [Ann Intern Med] 2006 Mar 07; Vol. 144 (5), pp. 326-36.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Aspirin/*economics
Aspirin/*therapeutic use
Coronary Disease/*prevention & control
Fibrinolytic Agents/*economics
Fibrinolytic Agents/*therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*economics
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Aspirin/adverse effects ; Computer Simulation ; Cost-Benefit Analysis ; Drug Costs ; Drug Therapy, Combination ; Fibrinolytic Agents/adverse effects ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Male ; Markov Chains ; Middle Aged ; Primary Prevention ; Quality-Adjusted Life Years ; Risk Factors ; Sensitivity and Specificity ; Stroke/chemically induced
Czasopismo naukowe
Tytuł :
Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease.
Autorzy :
Pignone M
Mulrow C
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2002 Apr 13; Vol. 324 (7342), pp. 917.
Typ publikacji :
Letter
MeSH Terms :
Aspirin/*therapeutic use
Coronary Disease/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Humans ; Patient Selection ; Risk Factors
Opinia redakcyjna
Tytuł :
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.
Autorzy :
Hayden M; Division of General Medicine, Department of Medicine, 11C Ambulatory Care, Veterans Administration Medical Center, USA.
Pignone M
Phillips C
Mulrow C
Pokaż więcej
Źródło :
Annals of internal medicine [Ann Intern Med] 2002 Jan 15; Vol. 136 (2), pp. 161-72.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Aspirin/*therapeutic use
Coronary Disease/*prevention & control
Fibrinolytic Agents/*therapeutic use
Adult ; Aged ; Aspirin/adverse effects ; Chemoprevention ; Coronary Disease/epidemiology ; Evidence-Based Medicine ; Female ; Fibrinolytic Agents/adverse effects ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Primary Prevention ; Risk Factors ; Stroke/chemically induced ; Stroke/prevention & control ; United States/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies